Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Sep 3, 2010

Premium

Les Paul this week joined Caris Life Sciences as senior vice president, medical affairs. In this role he will lead efforts to inform clinicians about the company's products and direct post-market studies designed to demonstrate their clinical value, the company said.

Previously Paul was head of clinical and scientific affairs for the National Pharmaceutical Council, and prior to that he worked for Novartis and AstraZeneca.


PharmaNet Development Group this week appointed Anthony Maida vice president, clinical research.

Previously Maida ran a private consulting firm focusing on raising capital for pharmaceutical product development. Before that be worked for Lockheed. He has a PhD in tumor immunology from the University of California, Davis.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.